- PF-06454589
-
- $46.00 / 5mg
-
2024-11-15
- CAS:1527473-30-8
- Min. Order:
- Purity: 96.29%
- Supply Ability: 10g
|
| 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine Basic information |
Product Name: | 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine | Synonyms: | 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine;PF-06454589;CS-2879;PF-06454589 ;PF 06454589 ;PF06454589;Inhibitor,G2019S LRRK2,inhibit,LRRK2,parkinson's disease,PF06454589,PF 06454589,PF-06454589,Leucine-rich repeat kinase 2;7H-Pyrrolo[2,3-d]pyrimidine, 5-(1-methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-;4-[5-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine | CAS: | 1527473-30-8 | MF: | C14H16N6O | MW: | 284.32 | EINECS: | | Product Categories: | | Mol File: | 1527473-30-8.mol | |
| 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine Chemical Properties |
density | 1.49±0.1 g/cm3(Predicted) | storage temp. | room temp | solubility | DMSO: soluble10mg/mL, clear | form | powder | pka | 13.16±0.50(Predicted) | color | white to beige |
Hazard Codes | Xn | Risk Statements | 22 |
| 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine Usage And Synthesis |
| 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine Preparation Products And Raw materials |
|